grow.

Strategy

Biotech

Leading biotechnology innovators

By Grow

Biotechnology companies are developing the next generation of therapies across gene editing, immunology, and novel drug platforms. On a set weekly cadence, the portfolio rebalances when any holding drifts more than 5% from its target weight.

Allocation

Thematic
  • Amgen13%
  • Regeneron Pharmaceuticals13%
  • Moderna13%
  • Vertex Pharmaceuticals13%
  • Capricor Therapeutics13%
  • Enlivex Therapeutics13%
  • AbbVie13%
  • Pfizer13%

Copy this strategy in Grow

Open the app, pick your amount, and Grow keeps the allocation on target for you.

Get Grow

Allocations shown are targets and may drift between rebalances. Investments involve substantial risk, including the possible loss of principal.